test

Jared Keller

@Kynam Capital Management, Lp

Latest period2024 - Q3ReportedManaged Assets$1.304BTotal holdings25
Assets growth rate0.63%Assets growth rate (2-Q avg)18.16%Continuous growth in asset value4 quarters

Portfolio positions

This chart displays the top 10 holdings in Kynam Capital Management, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 25 positions.

Assets under management

The assets under management (AUM) of Kynam Capital Management, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.304B in assets, with a quarterly growth rate of 0.63% and a 2-quarter average growth rate of 18.16%. The portfolio is managed by Jared Keller, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
NTRANatera Inc
Recent Activity
Increased 1.4%
19.88%
$259.292M
2.042M shares@ $126.95 avg price
PCVXVaxcyte Inc
Recent Activity
Increased 37.98%
9.11%
$118.759M
1.039M shares@ $114.28 avg price
CLDXCelldex Therapeutics Inc New
Recent Activity
Increased 2.06%
9.02%
$117.558M
3.459M shares@ $34.0 avg price
SNDXSyndax Pharmaceuticals Inc
Recent Activity
Increased 2.12%
8.63%
$112.476M
5.843M shares@ $19.25 avg price
COGTCogent Biosciences Inc
Recent Activity
Decreased -0.22%
7.65%
$99.789M
9.24M shares@ $10.81 avg price
DVAXDynavax Technologies Corp
Recent Activity
Increased 17.66%
7.12%
$92.826M
8.333M shares@ $11.14 avg price
VERAVera Therapeutics Inc
Recent Activity
Increased 2.13%
5.35%
$69.683M
1.577M shares@ $44.21 avg price
BCRXBiocryst Pharmaceuticals Inc
Recent Activity
Increased 2.94%
5.3%
$69.049M
9.085M shares@ $7.61 avg price
CGONCg Oncology Inc
Recent Activity
Increased 3184.69%
5.13%
$66.812M
1.771M shares@ $37.74 avg price
VRDNViridian Therapeutics Inc
Recent Activity
Increased 43.51%
4.38%
$57.132M
2.511M shares@ $22.75 avg price